XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.1
Marketable Securities (Tables)
3 Months Ended
Mar. 31, 2022
Investments, Debt and Equity Securities [Abstract]  
Schedule of Marketable Securities

The following is a summary of available-for-sale marketable securities, excluding those securities classified within cash and cash equivalents on the Condensed Consolidated Balance Sheet as of March 31, 2022 and December 31, 2021 were as follows (in thousands):

 

 

March 31, 2022

 

 

Amortized Cost

 

 

Unrealized Gain

 

 

Unrealized Losses

 

 

Fair Value

 

Commercial paper

$

6,282

 

 

$

-

 

 

$

-

 

 

$

6,282

 

Corporate bonds

 

2,822

 

 

$

-

 

 

$

(8

)

 

 

2,814

 

U.S. treasury securities

 

12,054

 

 

$

-

 

 

$

(69

)

 

 

11,985

 

Marketable securities

$

21,158

 

 

$

-

 

 

$

(77

)

 

$

21,081

 

 

 

December 31, 2021

 

 

Amortized Cost

 

 

Unrealized Gain

 

 

Unrealized Losses

 

 

Fair Value

 

Commercial paper

$

5,580

 

 

$

-

 

 

$

-

 

 

$

5,580

 

Corporate bonds

 

2,129

 

 

$

-

 

 

$

(1

)

 

 

2,128

 

U.S. treasury securities

 

6,060

 

 

$

-

 

 

$

(3

)

 

 

6,057

 

Marketable securities

$

13,769

 

 

$

-

 

 

$

(4

)

 

$

13,765

 

Schedule of fair values of available-for-sale marketable securities

As of March 31, 2022, the fair values of available-for-sale marketable securities, by remaining contractual maturity, were as follows (in thousands):

 

 Due within one year

 

 

 

 

 

$

20,380

 

 Due in one to two years

 

 

 

 

 

$

701

 

Total

 

 

 

 

 

$

21,081